echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > 【Nature Sub-journal】Zhu Zhenggang of Shanghai Jiao Tong University and other teams published a pangenomic analysis of gastric cancer in China

    【Nature Sub-journal】Zhu Zhenggang of Shanghai Jiao Tong University and other teams published a pangenomic analysis of gastric cancer in China

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is the original of the translational medicine network, please indicate the source when reprinting

    Author: Mia

    Pangenomics research will hopefully improve the integrity of the human reference genome (GRCh38) and promote precision medicine


    On September 15, Prof.


    background


     01 

    Since its first release 20 years ago, the human reference genome (current version GRCh38) has significantly facilitated extensive biomedical research


    Pangenomics was first proposed in 2005 as a collection of microbial population genes that study patterns


    The pangenome contains two types of genes, the core gene shared by all individuals and the distribution gene


    In previous studies, the research team developed a human pangenomic analysis (HUPAN) tool for constructing human pangenomes from WGS data and characterizing


    Research overview

     02 

    Using HUPAN, the research team collected 185 pairs (370 samples) of WGS data


    The researchers found that four distribution genes, ACOT1, GSTM1, SIGLEC14, and UGT2B17, exhibited extremely high deletion frequencies in gastric cancer populations


    Both genes UGT2B17 and GSTM1 are enriched


    Paradigm of deletion variation and functional enrichment of distributed genes

    The research team also successfully characterized a gene, GC0643


    In addition, they found that GC0643 was missing not only at the somatic level, but also


    Research summary

     03 

    In conclusion, the researchers developed a new cancer genomics research strategy by combining human reference genomes and non-reference sequences


    Resources:

    This article is intended to introduce medical research advances and cannot be used as a reference for


    Recommended Live/Events

    09/27 14:00-17:30 Shanghai

    Innovative technology to facilitate the summit forum on accurate diagnosis and treatment of tumors

    Scan the code to participate for free

    November 03-04 09:00-17:30 Shanghai

    The 3rd Yangtze River Delta In Vitro Diagnostic Industry Forum

    Scan the code to participate for free

    November 25-27 09:00-17:30 Shanghai

    The 4th Shanghai International Cancer Congress

    Scan the code to participate

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.